Protecting Democracy [1]

American democracy is in jeopardy, from the disastrous Citizens United ruling that flooded our politics with corporate cash to the immoral assault on voting rights. We work every day to defend against these threats and advance bold reforms.

Tell Congress: Pass the Protecting Our Democracy Act

Add Your Name

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats
Making Government Work [2]

The U.S. government should work for the public, not corporations or industry. It should safeguard consumers, workers and the environment, and be funded well enough to do so. The budget process must not be obstructed by partisanship.

Get Corporate Money Out of Politics

Sign the Petition

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity
Consumer & Worker Safeguards [3]

Every day, Big Banks, Big Polluters, and Big Tech companies are threatening our economy, our environment, and our democracy – sacrificing Main Street Americans and our families on the altar of corporate profits. Public Citizen advocates for ordinary people by taking on corporate interests and their cronies in government.

Don’t Let Big Tech Write Our Digital Privacy Laws

Sign Now

Dozens of Commonsense Safeguards Vulnerable to GOP Rollback

Crypto Promoter Paul Atkins Named to Chair SEC
Safe & Affordable Drugs & Devices [4]

Prescription drugs are unaffordable and new drugs and devices often are approved without being proven safe and effective. Public Citizen challenges Big Pharma, device manufacturers and federal regulators to make drugs and medical devices safe, effective and accessible to all.

Tell President Biden: Make Meds Affordable

SEND AN EMAIL
Health Care [5]

Health care in the U.S. leaves too many people out, costs too much and doesn’t meet acceptable standards of quality. Much of the care that we get is unaffordable, unnecessary or harmful. Public Citizen advocates Medicare for All, stronger oversight of dangerous doctors and safe clinical trials.

Win Medicare for All

Take Action Now

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023

Report: Thirty-One Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991-2021
Globalization & Trade [6]

Global Trade Watch’s mission is to ensure that in this era of globalization, a majority have the opportunity to enjoy economic security, a healthy environment, safe food, medicines and products, access to quality affordable services such as health care and the exercise of democratic decision-making about the matters that affect our lives.

Global Trade Watch has led the fight against corporate-rigged “trade” agreements that provide special powers for Big Pharma to raise medicine prices, promote the outsourcing of jobs to low-wage countries and undermine the food safety and other safeguards on which our families rely.

For decades, we have fought for progressive alternatives that benefit people and the planet. Learn more about our work.

Join the Trade Justice Movement

JOIN NOW
Climate & Energy [7]

The climate crisis is the challenge of our time. We can fix it with solutions that will make us healthier and more economically secure. We must act quickly to make our economy run on renewable power — and ensure that disadvantaged families and displaced workers share equitably in the new economy. We also must fight the corrupting power of fossil fuel companies and ensure that energy regulators are effective and publicly accountable.

Tell Toyota: Go all-in on EVs

Add Your Name

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record
Justice & the Courts [8]

Litigation can remedy or deter wrongdoing, impact policy and meaningfully slow abuses of power. Whether suing on behalf of our members to ensure the honest functioning of government, or representing individual consumers seeking redress in court, our litigation draws on our expertise in administrative law, constitutional law, and government transparency.

Subscribe to the Supreme Court Conference Preview

Sign Up

January 16, 2018

Panel Presentation at the Johns Hopkins University Bloomberg School of Public Health Symposium: Transparency at the U.S. Food and Drug Administration

View the PowerPoint Symposium Presentation.

View the video of the panel presentation.

Public Citizen advocated that the Food and Drug Administration follow the lead of its European and Canadian counterpart agencies and: 1) notify the public when an application to market a new drug or new use for an already-marketed drug is rejected by the agency or withdrawn by the company; and 2) release its analyses of data submitted in support of such rejected or withdrawn applications.

Menu

Tell Congress: Pass the Protecting Our Democracy Act

Generative Artificial Intelligence and Threats to Democracy

Protecting Elected Officials from Threats

Get Corporate Money Out of Politics

It’s Time to Cut the Bloated Pentagon Budget to Fund People, Not Military Contractors

Ensuring Public Money Does Not Go To Private Equity

Don’t Let Big Tech Write Our Digital Privacy Laws

Dozens of Commonsense Safeguards Vulnerable to GOP Rollback

Crypto Promoter Paul Atkins Named to Chair SEC

Tell President Biden: Make Meds Affordable

Win Medicare for All

Report: Ranking of the Rate of State Medical Boards’ Serious Disciplinary Actions, 2021-2023

Report: Thirty-One Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991-2021

Join the Trade Justice Movement

Tell Toyota: Go all-in on EVs

Climate Roadmap for U.S. Financial Regulation

Toyota’s Troubling Electric Vehicle Track Record

Subscribe to the Supreme Court Conference Preview

Share

Panel Presentation at the Johns Hopkins University Bloomberg School of Public Health Symposium: Transparency at the U.S. Food and Drug Administration

Share

You might be interested in

Comments on Department of Education’s Proposed Borrower Defense Rule

Comments on the FDA’s Draft Guidance Regarding Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act

Letter to the U.S. House of Representatives Opposing Passage of the Senate’s “False Hope” Legislation

Statement by Dr. Sidney Wolfe at Press Conference Regarding Sweeping Pharmaceutical Reform Proposal Published in the British Medical Journal

Stay Updated on Public Citizen

Follow Public Citizen

Support Our Work